Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ofloxacin I.P. 200mg + Sodium Chloride I.P. 900mg Infusion
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
bottle
Packaging
100 ml
Price
₹196/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ofloglee Infusion is a combination of Ofloxacin, a broad-spectrum fluoroquinolone antibiotic, and Sodium Chloride, an isotonic solution used to restore electrolyte balance. This infusion is designed to effectively combat bacterial infections while ensuring proper hydration and electrolyte balance in patients. Ofloxacin acts by inhibiting bacterial DNA gyrase, which is essential for bacterial replication, thereby eliminating the infection.
Ofloglee Infusion is indicated for the treatment of a variety of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and gastrointestinal infections such as infectious diarrhea. The addition of Sodium Chloride aids in maintaining fluid balance, making it particularly useful for patients requiring intravenous therapy for moderate to severe infections.
This infusion is administered intravenously under the supervision of a healthcare professional, ensuring a controlled and steady release of the active ingredients for optimal therapeutic outcomes. It offers rapid relief from symptoms and is particularly beneficial for patients unable to tolerate oral medications.
Common side effects include nausea, diarrhea, dizziness, and injection site reactions. Rarely, allergic reactions or tendonitis may occur.
Ofloglee Infusion is indicated for bacterial infections, including respiratory, urinary, skin, soft tissue, and gastrointestinal infections.
This medication should only be administered by a healthcare professional. Complete the full course of treatment to prevent antibiotic resistance.
Store below 30°C. Protect from light and keep out of reach of children.
Composition : Ofloxacin (200mg) Tablet
Composition : Ofloxacin (0.3% w/v) + Dexamethasone (0.1% w/v) + Hydroxypropylmethylcellulose (0.25% w/v)
Composition : Ofloxacin (50mg) + Metronidazole (120mg) + Simethicone (10mg)
Composition : Ofloxacin (50mg) + Ornidazole (125mg) + Racecadotril (15mg)
Composition : Ofloxacin (200mg) + Ornidazole (500mg)
Composition : Ofloxacin (50mg/5ml)
Composition : Norfloxacin (400mg) + Tinidazole (600mg)
Composition : Amoxycillin (400mg/5ml) + Clavulanic Acid (57mg/5ml)
Composition : Amoxycillin (250mg) + Clavulanic Acid (125mg)
Composition : Amoxycillin (200mg) + Clavulanic Acid (28.5mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ofloxacin 200 mg Infusion is a fluoroquinolone antibiotic injectable/IV infusion used for the treatment of moderate to severe bacterial infections, including respiratory tract infections, urinary tract infections, gastrointestinal infections, skin and soft tissue infections, and hospital-acquired infections. It provides rapid systemic action in critical and inpatient cases, making it a strong hospital and critical-care anti-infective segment product.
Medical distributors and wholesalers can benefit from consistent hospital demand, emergency usage, and physician/surgeon prescriptions. Antibiotic infusions are widely used in inpatient care, ICU, and post-surgical infection management, ensuring regular institutional orders and strong turnover.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in anti-infective, critical care, and hospital injectable/infusion segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and institutional suppliers benefit from high hospital consumption, surgical infection management needs, and continuous inpatient antibiotic usage, making it a stable, high-volume, and hospital-driven pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in critical-care antibiotic infusions can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the hospital and anti-infective segment.